Drug manufacturers have increased their production, and some such as Novo Nordisk have asked the FDA to ban further production of compounded versions of their drugs. If that happens, Lavin says many ...

(Bloomberg) -- Obesity pill data released by Viking Therapeutics Inc. and AstraZeneca Plc at a big conference foreshadowed an increasingly competitive landscape for weight-loss therapies ...

LONDON, United Kingdom - AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an early-stage trial, with side effects consistent with ...

Virat Kohli and Rohit Sharma came under fire Monday as India chewed over a 3-0 Test series home defeat to New Zealand, with critics calling the team ageing and low on confidence. The cricket ...

Novo and Lilly are also working on oral weight loss drugs. In September, Novo released phase 2b data on monlunabant, a cannabinoid receptor 1 (CB1) inverse agonist, though the results appeared to ...

"Losing 3-0 at home is a tough pill to swallow and it calls for introspection," former skipper Sachin Tendulkar wrote on social media. "Was it lack of preparation, was it poor shot selection or ...

similar to other obesity drugs. VK2735 is a dual GLP-1/GIP receptor agonist similar to Eli Lilly's (LLY) blockbuster weight loss drug Zepbound, designed to treat obesity and other metabolic disorders.

Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a highly anticipated oral pill. The San Diego-based company’s stock ...

GREEN BAY, WI (WNFL/LEARFIELD) – The Green Bay Packers lost to the Detroit Lions 24-14 at Lambeau Field in Green Bay on Sunday. It was a problem-filled loss for the Packers including 10 penalties, 3 ...

From all-in-one fat burners like Zmyra to natural powerhouses like green tea extract and ... When considering supplements for weight loss, the ideal pill should have a blend of ingredients that ...

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so predictable routine of online meetings, phone calls, and ...

Jefferies analyst Roger Song in an investor note said that Viking Therapeutics’ readout for its investigational therapy VK2735 exceeded expectations, with “class-leading” weight loss. Patients on ...